Simplifying Global Compliance
Shire Plans to Complete Two More ProAmatine Trials by 2014
Washington Drug Letter
Shire expects to complete two additional efficacy trials of blood-pressure drug ProAmatine by 2014 after reaching an agreement with CDER for postmarket trials of the accelerated approval drug.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing